title: Oncolytic immunotherapeutic virus in HCC: can it compete with molecular therapies?
authors.affiliation: HCC Translational Research Laboratory, Barcelona-Clínic Liver Cancer Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Universitat de Barcelona (UB), Barcelona, Catalonia, Spain.
authors.forename: Virginia
authors.initials: V
authors.lastname: Hernandez-Gea
authors.forename: Clara
authors.initials: C
authors.lastname: Alsinet
authors.forename: Josep M
authors.initials: JM
authors.lastname: Llovet
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D050130:Oncolytic Virotherapy; D014616:Vaccinia virus / Q000235:genetics*
keywords: Hepatocellular carcinoma; Immunotherapy; Oncolytic virus